PAA
Peregrine Asset Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-403
| Closed | -$424K | – | 185 |
|
|
2024
Q3 | $424K | Buy |
+403
| New | +$424K | 0.15% | 112 |
|
|
2024
Q2 | – | Sell |
-303
| Closed | -$292K | – | 182 |
|
|
2024
Q1 | $292K | Hold |
303
| – | – | 0.12% | 133 |
|
|
2023
Q4 | $266K | Hold |
303
| – | – | 0.13% | 129 |
|
|
2023
Q3 | $249K | Hold |
303
| – | – | 0.13% | 125 |
|
|
2023
Q2 | $218K | Hold |
303
| – | – | 0.17% | 69 |
|
|
2023
Q1 | $249K | Sell |
303
-400
| -57% | -$329K | 0.24% | 57 |
|
|
2022
Q4 | $507K | Buy |
+703
| New | +$507K | 0.54% | 31 |
|
|
2021
Q4 | – | Sell |
-4,162
| Closed | -$2.52M | – | 149 |
|
|
2021
Q3 | $2.52M | Buy |
+4,162
| New | +$2.52M | 1.29% | 29 |
|
|
2020
Q3 | – | Sell |
-7,170
| Closed | -$4.47M | – | 114 |
|
|
2020
Q2 | $4.47M | Buy |
7,170
+2,537
| +55% | +$1.58M | 2.54% | 12 |
|
|
2020
Q1 | $2.26M | Buy |
+4,633
| New | +$2.26M | 1.7% | 17 |
|